Double-click to edit
Tap to edit

Welcome to the GenomEast Platform

The GenomEast Platform, hosted at the IGBMC, is a partner of the National Research Infrastructure “France Genomique”. With an experience of over 15 years, we offer a wide range of services to survey genomes, their expression and their regulation, from quality check of starting material up to data analysis. These services are intended for the entire scientific community, national and international, public and private.

Currently equipped with an Illumina HiSeq 4000, we routinely perform ChIP-seq, DNA-seq and RNA-seq analyses using a large variety of protocols and we have developed dedicated bioinformatics pipelines to analyze the corresponding results. We have also experience in single cell RNA-seq analysis using Fluidigm microfluidic system or FACS sorting coupled to BD™ precise assays. Finally, we propose gene expression analysis down to the single-cell level by high-throughput Q-PCR with Fluidigm Biomark™ technology.

ISO_9001_and_NFX_50-900 To maintain high-level scientific services, we are committed to a quality approach according to ISO 9001 standard for which we have been certified since January 2007. We strengthened this quality commitment in January 2016 by meeting the requirements of NF X 50-900 standard, a French system of reference in accordance with the scientific, technical and management exigencies of life science technology platforms ( Icon Scientific and quality policy of the GenomEast Platform (340.1 KB) ).

Last update on Fri 13 Jul 2018


logo-france-genomique.png logo-ibisa.png logo-cnrs.png logo-uds.png logo-inserm.png logo-ligue-cancer.png


2018-09-13: 2017, a year with the CNRS in Alsace


2018-07-11: 2017 Activity Report


2018-07-04: Transcription defects related to the XPC factor implicated in the disease of children of the moon


2018-06-01: Identification of MOSPD2, a novel molecular velcro bridging cellular organelles with the endoplasmic reticulum


2018-04-13: Transcription and intellectual disability: a mutation resulting in the almost complete loss of a general transcription factor has a much less severe effect than expected